|
Tags:, sulfonylurea drugs, light, dosage form
(View ID:527166)
new long-acting sulfonylureas Drugs, or when the new light diabetic patiENTs 90% about 2 diabetes, including 70% ~ 85% oral hypoglycemic medication, only the 15% ~ 30% ~ 3 years, and most also need the addition of oral antidiabetic Drugs to make blood sugar control satisfaction.In the five classes of oral hypoglycemic drugs, sulfonylurea reliable hypoglycemic effect, is the most widely used, most widely used oral antidiabetic drugs. sulfonylurea has been around for more than half a cENTury, is a member of numerous Family.The first-generation drug (tolbutamide and methyl chloride, propylene urea, etc.) due to dose, hypoglycemic effect is weak, side effects, clinical rarely use.Second-generation sulfonylureas, including glibenclamide, gliclazide, glipizide and other hypoglycemic ability, but low blood sugar, weight gain and risk repeatedly taking become a major obstacle to clinical application.
glimepiride rely on their own metabolic characteristics to achieve long-term purpose. glipizide controlled-release tablets is glipizide plain film The formulations improvemENTs.The glipizide plain film has a higher insulin secretion peak, and daily 2 taking, will be replaced by the controlled release dosage form to ensure that medicines are to release a constant, thus avoiding excessive insulin secretion peak, and a day 1 use. gliclazide MR innovative sustained release formulations, 1 day 1 under the premise of the dose to ensure that the hypoglycemic effect of the better during the day and night less hypoglycemia and weight gain, providing a smarter blood glucose control.
, sulfonylurea drugs, light, dosage form, long-lasting, weight gain, class of antidiabetic drugs, insulin secretion, diabetes, blood glucose control
|
|
|
